NASDAQ: INTS
Intensity Therapeutics Inc Stock Ownership - Who owns Intensity Therapeutics?

Insider buying vs selling

Have Intensity Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Joseph TalamoChief Financial Officer2026-06-301,093$3.49
$3.81kBuy
John M. WesolowskiPrincipal Accounting Officer2026-06-303,688$3.49
$12.85kBuy
Lewis H. BenderPresident and CEO2026-03-2637,749$6.11
$230.65kBuy
Joseph TalamoChief Financial Officer2025-12-3114,482$0.26
$3.79kBuy
John M. WesolowskiPrincipal Accounting Officer2025-12-318,918$0.26
$2.34kBuy

1 of 1

INTS insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when INTS insiders and whales buy or sell their stock.

INTS Shareholders

What type of owners hold Intensity Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Lewis H. Bender3.59%118,549$294.00kInsider
John M. Wesolowski0.22%7,102$17.61kInsider
Joseph Talamo0.07%2,239$5.55kInsider
Kingsbury Capital Investment Advisors LLC0.02%706$1.75kInstitution
Rothschild Wealth LLC0.00%29$71.92Institution
Vanguard Capital Management LLC0.00%26$64.48Institution
Nano Cap New Millennium Growth Fund L P0.00%25$62.00Institution
Geode Capital Management LLC0.00%22$54.56Institution
Vanguard Fiduciary Trust Co0.00%21$52.08Institution
Fny Investment Advisers LLC0.00%15$37.20Institution

1 of 2

INTS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
INTS0.03%3.87%Net Buying
INAB0.02%99.98%Net Buying
MBRX0.01%99.99%Net SellingNet Selling
PTN0.00%100.00%Net Selling
MTRI0.05%99.95%Net BuyingNet Buying

Intensity Therapeutics Stock Ownership FAQ

Who owns Intensity Therapeutics?

Intensity Therapeutics (NASDAQ: INTS) is owned by 0.03% institutional shareholders, 3.87% Intensity Therapeutics insiders, and 96.10% retail investors. Lewis H. Bender is the largest individual Intensity Therapeutics shareholder, owning 118,549.00 shares representing 3.59% of the company. Lewis H. Bender's Intensity Therapeutics shares are currently valued at $294.00k.

If you're new to stock investing, here's how to buy Intensity Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.